← Leaderboards
Thomas Duane Coates
University Of Southern California
$9,016,159
Attributed
$16,519,489
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–17$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$17,884,767 · 13
CDC$1,198,750 · 2
By mechanism
U01$10,529,656 · 2
U54$4,432,161 · 4
P60$2,225,461 · 1
R01$1,141,438 · 1
P41$311,528 · 1
U50$292,500 · 1
Top collaborators
- Michael C.K. Khoo7 shared
- John C Wood7 shared
- Lonnie K Zeltzer7 shared
- Herbert J Meiselman4 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Herbert J Meiselman$8,839,184
- John C Wood$11,655,933
- Michael C.k. Khoo$7,950,904
- Vijay K. Kalra$5,424,996
- Francine R. Kaufman$3,074,581
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaHuman SubjectMonitorSickle CellResearch PersonnelBlood FlowCerebrumSecondary ToSickle HemoglobinCardiacSicklingTransfusionAutonomic Nervous SystemBaseHematological DiseaseClinical ResearchBlood VesselsCommunitiesChronicOxygenProgramsMeasurementInterestMagnetic Resonance Imaging
Grant awards (43)
Multimodal biophysical markers of vascular disease in hemoglobinopathies$1,951,001
U01 · FY2017 · HL · contact PI
Neuromodulatory Mechanisms and Regional Autonomic Dysregulation in the Development of Pain in Sickle Cell Disease Patients$43,182
U01 · FY2017 · HL · contact PI
Multimodal biophysical markers of vascular disease in hemoglobinopathies$1,913,722
U01 · FY2016 · HL · contact PI
Multimodal biophysical markers of vascular disease in hemoglobinopathies$1,889,463
U01 · FY2015 · HL · contact PI
Multimodal biophysical markers of vascular disease in hemoglobinopathies$1,879,872
U01 · FY2014 · HL · contact PI
Multimodal biophysical markers of vascular disease in hemoglobinopathies$4,792
U01 · FY2014 · HL · contact PI
Multimodal biophysical markers of vascular disease in hemoglobinopathies$1,941,374
U01 · FY2013 · HL · contact PI
SOUTHERN CALIFORNIA BLOOD SAFETY SURVEILLANCE PROGRAM IN HEMATOLOGICAL DISORFERS$142,500
U50 · FY2013 · DD · contact PI
SOUTHERN CALIFORNIA BLOOD SAFETY SURVEILLANCE PROGRAM IN HEMATOLOGICAL DISORFERS$150,000
U50 · FY2012 · DD · contact PI
Basic and Translational Research Program$613,128
U54 · FY2011 · HL · contact PI
Impact of Blood Viscosity on Oxygen Delivery in humans with Sickle Cell Anemia$363,430
U54 · FY2011 · HL · contact PI
Sickle Cell Scholar Component$165,376
U54 · FY2011 · HL · contact PI
Research Initiatives for the Preventions of Complications of Thalassemia$150,000
U01 · FY2011 · DD · contact PI
Administration Core$84,322
U54 · FY2011 · HL · contact PI
Research Initiatives for the Preventions of Complications of Thalassemia$150,000
U01 · FY2010 · DD · contact PI
Basic and Translational Research Program$1,312,589
U54 · FY2009 · HL · contact PI
Impact of Blood Viscosity on Oxygen Delivery in humans with Sickle Cell Anemia$366,997
U54 · FY2009 · HL · contact PI
Research Initiatives for the Preventions of Complications of Thalassemia$200,000
U01 · FY2009 · DD · contact PI
Sickle Cell Scholar Component$165,375
U54 · FY2009 · HL · contact PI
Administration Core$84,322
U54 · FY2009 · HL · contact PI
HUMAN MODELS OF SICKLE CELL VASCULAR DAMAGE$12,755
M01 · FY2009 · RR · contact PI
Comprehensive Sickle Cell Center$638,311
U54 · FY2008 · HL · contact PI
Impact of Blood Viscosity on Oxygen Delivery in humans with Sickle Cell Anemia$388,614
U54 · FY2008 · HL · contact PI
Research Initiatives for the Preventions of Complications of Thalassemia$200,000
U01 · FY2008 · DD · contact PI
Sickle Cell Scholar Component$165,375
U54 · FY2008 · HL · contact PI
Administration Core$84,322
U54 · FY2008 · HL · contact PI
HUMAN MODELS OF SICKLE CELL VASCULAR DAMAGE$45,667
M01 · FY2008 · RR · contact PI
Research Initiatives for the Preventions of Complications of Thalassemia$206,250
U01 · FY2007 · DD · contact PI
HUMAN MODELS OF SICKLE CELL VASCULAR DAMAGE$36,827
M01 · FY2007 · RR · contact PI
Human models of sickle cell vascular damage$290,606
R01 · FY2006 · HL · contact PI
HUMAN MODELS OF SICKLE CELL VASCULAR DAMAGE: (AIM2) RESPONSE OF PLASMA MARKERS$29,395
M01 · FY2006 · RR · contact PI
HUMAN MODELS OF SICKLE CELL VASCULAR DAMAGE$26,129
M01 · FY2006 · RR · contact PI
Human models of sickle cell vascular damage$279,544
R01 · FY2005 · HL
Human models of sickle cell vascular damage$279,544
R01 · FY2004 · HL
Human models of sickle cell vascular damage$291,744
R01 · FY2003 · HL
LEUKOCYTE ACTIVATION AND RHEOLOGY IN SICKLE CELL DISEASE--VASCULAR OCCLUSION$498,057
P60 · FY2002 · HL
LEUKOCYTE ACTIVATION AND RHEOLOGY IN SICKLE CELL DISEASE--VASCULAR OCCLUSION$498,057
P60 · FY2002 · HL
LEUKOCYTE ACTIVATION AND RHEOLOGY IN SICKLE CELL DISEASE--VASCULAR OCCLUSION$498,057
P60 · FY2002 · HL
MODELING OF NEUTROPHIL MOTILITY$155,764
P41 · FY2002 · RR
LEUKOCYTE ACTIVATION AND RHEOLOGY IN SICKLE CELL DISEASE--VASCULAR OCCLUSION$498,057
P60 · FY2001 · HL
MODELING OF NEUTROPHIL MOTILITY$155,764
P41 · FY2001 · RR
LEUKOCYTE ACTIVATION AND RHEOLOGY IN SICKLE CELL DISEASE--VASCULAR OCCLUSION$233,233
P60 · FY2000 · HL
MODELING OF NEUTROPHIL MOTILITY$0
P41 · FY2000 · RR